ArticleJournal of translational medicine2026

A novel combination for in vivo breast cancer treatment: TAK1 inhibition combined with metformin and Lentinula edodes compounds synergistically reinvigorates CD8

Amir Saeid Mahdavi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.